The University of Wisconsin Carbone Cancer Center (UWCCC) holds the unique distinction of being the only comprehensive cancer center in Wisconsin, as designated by the National Cancer Institute, the lead federal agency for cancer research. Every day on the UW – Madison campus, thousands of dedicated individuals work meticulously to find the best ways to prevent, detect, diagnose, and treat cancer.
An integral part of the UW School of Medicine and Public Health, the UWCCC unites more than 280 physicians and scientists who work together in translating discoveries from research laboratories into new treatments that benefit cancer patients. The UWCCC conducts clinical cancer trials in all phases, and supports a broad portfolio of studies, including investigator initiated, NCI cooperative group studies and industry studied investigations of new agents. The organization also has a burgeoning cellular therapy program.
More than 30,000 people are seen annually for diagnosis, therapy, follow-up care or consultations at UW Hospital and Clinics, as well as our other clinical locations.
The following is a list of myeloma clinical trials at this center.
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
The following is a listing of clinical trials for patients with Smoldering Myeloma.
SparkCures is working closely with UW Carbone Cancer Center to provide the most up-to-date information on their myeloma program, specialists and clinical trials. Use the buttons above to claim this as your Home Center or add it to your List of Favorites.
Learn more about how we work with myeloma centers